Volume 9 Supplement 1
The fallacy of coverage: uncovering disparities to improve immunization rates through evidence. Results from the Canadian International Immunization Initiative Phase 2 - Operational Research Grants
© Mhatre and Schryer-Roy; licensee BioMed Central Ltd 2009
Published: 14 October 2009
Immunization can and does save lives. However, the presence of vaccines does not easily translate into every child being vaccinated, and this is what the studies in this journal supplement reveal. From South Asia to West Africa,the evidence presented here reveals what we are calling the fallacy of coverage, going beyond uncovering the real vaccination rates to providing evidence on the reasons for the lack of effective coverage.
The evidence for the fallacy of coverage is part of an operational research program entitled the Canadian International Immunization Initiative Phase 2 (CIII2). Through a competitive peer review process, six research grants were awarded to increase access to and enhance immunization services. This journal supplement provides a forum for the presentation of the results of five of the six studies.
The story of the fallacy of coverage is made up of five theme areas of evidence - timeliness of immunization, social and gender inequities, vaccine efficacy, understanding demand side issues to tailor interventions, and national data sets masking actual district level coverage rates - that reveal the discrepancies in immunization coverage rates and the reasons behind these discrepancies. As part of the story, and to turn around the fallacy of coverage, the studies also provide proof of effective and locally relevant solutions.
Policies and funding, while keeping an eye on future diseases, clearly need to maintain and increase support to address existing vaccine-preventable diseases to increase coverage such that by 2015 we can achieve 90% national vaccination coverage and reach the MDG of reducing mortality rates among children under five by two-thirds.The results from the operational research grants of the CIII2 offer some answers on how to reach this goal by demonstrating how locally generated evidence can inform immunization strategies to ensure that children who need to get vaccinated will get vaccinated, and vaccinated on time.
Immunization can and does save lives. With existing vaccines, it is estimated that between two and three million deaths from diphtheria, tetanus, pertussis and measles are prevented annually . There is a strong global recognition that increasing immunization coverage is an essential step towards reducing child mortality, the fourth Millennium Development Goal (MDG). Currently as a response, the chief goal set by UNICEF and WHO is to, by 2015 or earlier, reduce illness and death due to vaccine-preventable diseases by at least two thirds compared to 2000 levels.
Top vaccine-preventable diseases by region
Pertussis, Measles, Hep B
Latin America & Caribbean
The evidence for the fallacy of coverage is part of an operational research program entitled the Canadian International Immunization Initiative Phase 2 (CIII2), initiated in September 2003. This initiative is a project of the Global Health Research Initiative (GHRI), which involves the collaboration of five major research/health agencies in Canada: International Development Research Centre (IDRC), Canadian International Development Agency (CIDA), Canadian Institutes of Health Research (CIHR), Health Canada (HC) and the Public Health Agency of Canada (PHAC). It is an important precedent of funding organizations coming together, pooling resources and strengths, to invest in filling the gaps in immunization research.
Through a competitive peer review process, six research grants were awarded to increase access to and enhance immunization services in CIDA's priority countries. This journal supplement in BioMed Central's open access journal BMC International Health and Human Rights provides a forum for the presentation of the results of five of the six studies.
The first paper that follows provides a global overview of the progress to date in immunization and some of the challenges from the CIII2 partners. It discusses the various approaches used by WHO and UNICEF to improve immunization coverage and at the same time sets the stage for the research results of the CIII2 operational research grants by impressing on the need for evidence to realise the full potential of immunization "in achieving the health-related MDGs".
The subsequent 13 peer-reviewed papers unravel the fallacy of coverage and present the evidence for what is needed to get closer to achieving the fourth MDG. All the studies underline the importance of understanding the context in which the extent of immunization coverage is realised. Only through such operational and local research can we get the needed evidence to improve coverage - from South Asia to West Africa.
Theme areas of evidence
The story of the fallacy of coverage is made up of five theme areas of evidence that reveals the discrepancies in immunization coverage rates and the reasons behind these discrepancies. It also includes evidence for turning around this fallacy of coverage. The first theme is the challenge of timeliness or age-appropriate immunization. This is evident in the studies presented in this supplement from India , Pakistan [4, 8], and Burkina Faso [9, 10]. By assessing coverage through the analytical lens of age-appropriateness of coverage, these studies bring into question the progress of immunization coverage. In fact, as seen by the evidence, while overall coverage can be deceptively good, the story changes when one takes into account whether or not vaccines are administered on time. In India for example, while immunization coverage has overall increased, the work by Corsi et al.  shows that, nationally, complete age-appropriate coverage is still under 50%. Not only do age-appropriate immunization rates provide a truer picture of actual coverage, but such an approach is also useful for health workers and service providers - as noted in the work by Dugas et al.  and Bicaba et al.  - as it allows them to improve and tailor their immunization strategies to increase coverage. The implications for not providing immunization on time are reduced benefit of the vaccine and increased mortality.
The critical importance of the timely immunization theme was recently detailed in a review of data from 45 low-income and middle-income countries published in the Lancet.
The next key theme area of evidence to better understand the fallacy of coverage is the issue of social and gender equity. Work by Corsi et al.  demonstrates that the progress of immunization coverage in India is hindered by the persistence of gender inequities across all socio-economic levels, resulting in girls having significantly lower coverage rates for bacille Calmette-Guérin (BCG), oral polio vaccine (OPV), DPT and measles vaccination. Interestingly, gender inequities affect who gets immunized or not, but does not affect the decision to immunize on time. Gender also needs to be considered in targeting interventions, as demonstrated through an in-depth ethnographic study by Dugas et al.  in Burkina Faso. The researchers found that in some communities despite the father's decision to vaccinate the children, mothers do not always bring them to be immunized. This gap between decision-making and actual vaccination practice requires interventions that target both parents.
The linkage between poor coverage and increasing inequities is demonstrated in the studies in Pakistan and Burkina Faso. Mitchell et al.  provide evidence on how poor access and mother's education (in urban areas only) were the key equity factors obstructing measles vaccination uptake in the Lasbela district of Pakistan. In the Nouna district of Burkina Faso, Sanou et al.  provide evidence for how the education of both parents along with the economic conditions of households affected immunization coverage. The authors did note, however, that the influence of economic conditions is complex as immunization services are free of charge, thus pointing to the importance of communication about the free services to avoid potential abuses by providers.
In addition to inappropriate coverage and increasing inequities linked to coverage, the Pakistan study uncovered the next key theme area, which is that of vaccine efficacy. Through the development of a communication tool (a "balance sheet" summarizing published evidence on benefits and possible adverse effects of vaccination) to enable communities to balance costs and benefits of measles vaccination, Ledogar et al  uncovered a much lower vaccine efficacy rate in Lasbela, Pakistan, than expected. As such, the rate they found was 41.5% compared to the rate generally found in developed countries of 95% (range of 90-98%) . Reasons for this discrepancy are discussed in the paper. While this "balance sheet" was not used in the randomised controlled trial of a community intervention in Lasbela, Pakistan, such a tool could serve as a web-based reference for project managers and health officials, helping them identify areas of improvement in immunization services.
Many of the articles in this supplement offer a strong demand side perspective, i.e. from existing and potential beneficiaries. This demand side evidence is the next key theme area which looks behind the discrepancies in vaccination rates to help tailor potential solutions. In the Pakistan series of articles, Shea et al.  conducted a systematic review of the literature on the impact of demand side interventions, demonstrating existing gaps and highlighting the need for such operational research. By focusing on the demand side, Dugas et al.  provide an increased understanding of why there is a lower than expected coverage rate in a health district in Burkina Faso. Their study points to the need to tailor interventions such that they take into account parents' perception of childhood illness and to the need to examine local vaccination procedures or requirements. In this particular case, their research found that vaccination procedures served to deter rather than ensure access. In practice, immunization access was conditional on women going for antenatal care and acquiring and preserving a vaccination booklet for their child. In the same vein, Bicaba et al.  argue for the importance of understanding the reasons why some children are still not completely vaccinated.
As part of a demand side analysis, understanding the local context is one of the keys to unravel the fallacy of coverage. Fourn et al.  in Benin ask the question: what are the factors that lead to reticence to vaccination among religious populations? Through the use of qualitative methods, their results suggest that interpretation of religious principles by church-going populations is primary in explaining reticence and that the solutions lie in creating an open dialogue among all actors: reticent parents, their religious leaders and health authorities. Such an intervention is also alluded to by the work in Burkina Faso by Sanou et al.  and national EPI teams have used the results of the study.
The local level analyses also provide valuable information on existing immunization programs/campaigns. For example, Mitchell et al.  note that while other areas in Pakistan have demonstrated the positive impact of mobile vaccination teams, this was not the case in Lasbela district. Similarly, as seen in Burkina Faso, Haddad et al note that Immunization Days did not have any impact on the performance of routine vaccination services. While both authors discuss this finding in their papers, it is worthy to note that these results from South Asia to West Africa further underscore that blueprint national programs/campaigns often do not resonate with communities as their assumptions are disconnected from local realities. Local data can be used to tailor such programs/campaigns to increase their effectiveness.
The studies in this supplement provided evidence from a local/district level and also compared their results to national data sets, thus presenting the last key theme area with regards to the fallacy of coverage. In the article by Cockroft et al.  the authors unravel a complex context where actual coverage rates are masked by national rates, and where there is heterogeneity in vaccination coverage between and within districts, and particularly between urban and rural areas in Pakistan. Despite this heterogeneity, as Cockroft et al.  point out, there is some commonality in the variables associated with vaccination uptake such as the quality of services, mother's education and knowledge of benefits. Local evidence on these issues can then be used to turn around the fallacy of coverage, thereby increasing immunization uptake.
Evidence of locally relevant solutions
Beyond the five key theme areas of evidence that emerge from this supplement, the various studies also highlight effective and locally relevant solutions that can lead to increased immunization coverage rates. This was the case in Pakistan, where as detailed by Andersson et al. , researchers addressed the challenge of low measles coverage rates in Lasbela district by introducing an intervention involving an evidence-based and structured series of community discussions of vaccination's costs and benefits. The effect of this intervention was tested using a randomised controlled trial without relying on improved health services. In fact, through this operational research the team, working with communities and health workers, doubled the odds of measles vaccination uptake (20% increase) and tripled the odds of completing full DPT vaccination (29% increase) for this district. The Pakistan study thus provides evidence on how to improve the demand side of vaccination uptake at a relatively low cost (US$9 per child). Interestingly, the work in Mali by Koumaré et al.  and in Burkina Faso by Sanou et al.  similarly underscore the need to give priority to providing information to communities on the goals of immunization as well as the importance of tailoring interventions to local realities to improve immunization uptake.
The evidence also points to the fact that improving coverage rates requires work not only on the demand side, but also on the supply side. As noted by Andersson et al.  in discussing the low efficacy rate of measles vaccine in Lasbela, Pakistan, improving service quality is needed to improve efficacy rates. As part of improving supply, the article by Djibuti et al.  focuses on health care providers and immunization managers in Georgia, documenting the effects of "supportive" supervision on the performance of the immunization program at the district level. Not surprisingly, within a framework of national immunization programs, such provider-based interventions can have a positive effect on coverage.
Finally, the last piece of evidence to help turn around the fallacy of coverage comes from the work by Haddad et al. , which focuses on system-related factors to explain disparities in immunization coverage among districts in Burkina Faso. By looking at a combination of factors (such as donor support, staffing standards, local strategies, immunization days and leadership by the district medical officer (DMO)) and their interaction, the authors conclude that the key is the "human factor" and the ability of good leadership to create the conditions for good performance. Even with limited access to donor supported initiatives or the presence of seasonal epidemics, with strong and committed leadership districts can adapt and perform well. Local strategies, as also demonstrated in the other studies, are also important and become more effective when linked to strong DMO leadership.
The articles are organised according to geography and research teams, starting in India and ending in Burkina Faso. Though, clearly the evidence repeats itself from South Asia to West Africa. Through locally based operational research, the story of the fallacy of coverage is revealed. Timeliness of immunization, social and gender inequities, vaccine efficacy, understanding demand side issues to tailor interventions, and national data sets masking actual district level coverage rates are the key theme areas of evidence. As part of the story, and to turn around the fallacy of coverage, the studies also provide proof of effective and locally relevant solutions: introducing structured series of community discussions on the cost-benefit of immunization, the role of supportive supervision and the role of strong leadership.
And such is the story of the fallacy of coverage, from South Asia to West Africa. The challenge now is how to build on the strength of the results and translate the evidence to global and national policies, programs and funding. This journal supplement is one step in that direction. At the same time, and as detailed by Duclos et al. , funding for improving immunization focuses not only on increasing coverage, but also on future diseases and vaccines. While it is important to keep an eye on future diseases, there is strong evidence - to which this supplement contributes - for the need to maintain and increase support to address existing vaccine-preventable diseases. While overall improvements in global coverage rates are undoubtedly taking place, in 2002 alone, it is estimated that 1.5 million children in all age groups died from diseases preventable by vaccines currently recommended by WHO (excluding measles) . In addition, disparities persist not only between countries and regions, but also within countries and districts. Thus, the question arises on how best to allocate funds to increase coverage such that by 2015 we can achieve 90% national vaccination coverage and reach the MDG of reducing mortality rates among children under five by two-thirds. The results from the operational research grants of the CIII2 offer some answers by demonstrating how locally generated evidence can inform immunization strategies to ensure that children who need to get vaccinated will get vaccinated, and vaccinated on time. We are making progress, however we still have a way to go.
List of abbreviations used
Millennium Development Goal
Diphtheria, Pertussis and Tetanus
Canadian International Immunization Initiative Phase 2
Global Health Research Initiative
International Development Research Centre
Canadian International Development Agency
Canadian Institutes of Health Research
Public Health Agency of Canada
Oral polio vaccine
District Medical Officer.
The views expressed in this preface are solely those of the authors and do not represent the views of the IDRC.
We would like to thank the GHRI and all its partner agencies - IDRC, CIDA, CIHR, HC and PHAC - for funding, creating and implementing the CIII2 operational research grants, including this journal supplement. We also wish to thank the members of the CIII2 subcommittee, who provided invaluable scientific advice and support throughout the entire CIII2 process (Garry Aslanyan, CIDA; Bhagirath Singh, CIHR; Ingrid Sketris, CIHR; Christina Zarowsky, IDRC; Paul Varughese, HC; and Geoff Black, CIDA). In addition, we would like to thank the Grants Administration Division at IDRC, particularly Mano Buckshi and Pascale Bruneau, for their constant support throughout this initiative and during the creation of this journal supplement.Thank you also to Aku Kwamie and Riswana Soundardjee for assisting in the beginning as the supplement was being formed. From BioMed Central, we are grateful for the support by Ros Dignon in the development of this supplement. Finally, special thanks to the 16 external reviewers who agreed to be part of this important initiative, and without whom this journal supplement would not have been possible.
This article is published as part of BMC International Health and Human Rights Volume 9 Supplement 1, 2009: The fallacy of coverage: uncovering disparities to improve immunization rates through evidence.The Canadian International Immunization Initiative Phase 2 (CIII2) Operational Research Grants. The full contents of the supplement are available online at http://www.biomedcentral.com/1472-698X/9?issue=S1.
- World Health Organization: WHO immunization work: 2006-07 highlights. 2008
- United Nation's Children's Fund: Annual report of the Executive Director: progress and achievements against the medium-term strategic plan. 2009
- World Health Organization: Global Immunization Strategy, Report by the Secretariat. Sixty First World Health Assemble. 2008, 10.1186/1472-698X-9-S1-S8.
- Andersson N, Cockroft A, Ansari NM, Omer K, Baloch M, Foster AH, Shea B: Evidence-based discussion increases childhood vaccination uptake: a randomised cluster controlled trial of knowledge translation in Pakistan. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S8-10.1186/1472-698X-9-S1-S13.PubMed CentralView ArticlePubMed
- Koumaré AK, Traore D, Haidara F, Sissoko F, Traoré I, Dramé S, Sangaré K, Diakité K, Coulibaly B, Togola B, MaÏga A: Evaluation of immunization coverage within the Expanded Program on Immunization in Kita Circle, Mali: a cross-sectional survey. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S13-10.1186/1472-698X-9-S1-S2.PubMed CentralView ArticlePubMed
- Duclos P, Okwo-Bele J-M, Gacic-Dobo M, Cherian T: Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S2-10.1186/1472-698X-9-S1-S3.View ArticlePubMed
- Corsi DJ, Bassani DG, Kumar R, Awasthi S, Jotkar R, Kaur N, Jha P: Gender inequity and age-appropriate immunization coverage in India from 1992 to 2006. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S3-10.1186/1472-698X-9-S1-S7.PubMed CentralView ArticlePubMed
- Mitchell S, Andersson N, Ansari NM, Omer K, Soberanis JL, Cockcroft A: Equity and vaccine uptake: a cross-sectional study of measles vaccination in Lasbela District, Pakistan. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S7-10.1186/1472-698X-9-S1-S9.PubMed CentralView ArticlePubMed
- Dugas M, DubÃ© E, KouyatÃ© B, Sanou A, Bibeau G: Portrait of a lengthy vaccination trajectory in Burkina Faso: from cultural acceptance of vaccines to actual immunization. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S9-10.1186/1472-698X-9-S1-S12.PubMed CentralView ArticlePubMed
- Bicaba A, Haddad S, Kabore M, Taminy E, Feletto M, Fournier P: Monitoring the performance of the Expanded Program on Immunization, the case of Burkina Faso. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S12-10.1186/1472-698X-9-S1-S10.PubMed CentralView ArticlePubMed
- Clark A, Sanderson C: Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet. 2009, 373: 1543-1549. 10.1016/S0140-6736(09)60317-2.View ArticlePubMed
- Sanou A, Simboro S, Kouyaté B, Gugas M, Graham J, Bibeau G: Assessment of factors associated with complete immunization coverage in children aged 12-23 months: a cross-sectional study in Nouna district, Burkina Faso. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S10-10.1186/1472-698X-9-S1-S6.PubMed CentralView ArticlePubMed
- Ledogar RJ, Fleming J, Andersson N: Knowledge synthesis of benefits and adverse effects of measles vaccination: the Lasbela balance sheet. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S6-10.1186/1472-698X-9-S1-S5.PubMed CentralView ArticlePubMed
- Centre for Disease Control, National Immunization Program: Measles and Measles Vaccine, Epidemiology and Prevention of Vaccine Preventable Diseases. 2007, [http://cdc.goc/vaccines/ed/vpd2007/download/slides.Measles10br.ppt]
- Shea B, Andersson N, Henry D: Increasing the demand for childhood vaccination in developing countries: a systematic review. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S5-10.1186/1472-698X-9-S1-S14.PubMed CentralView ArticlePubMed
- Fourn L, Haddad S, Fournier P, Gansey R: Determinants of parents' reticence toward vaccination in urban areas in Benin (West Africa). BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S14-10.1186/1472-698X-9-S1-S15.PubMed CentralView ArticlePubMed
- Haddad S, Bicaba A, Feletto M, Taminy E, Kabore M, Ouedraogo B, Contreras G, Larocque R, Fournier P: System-level determinants of immunization coverage disparities among health districts in Burkina Faso:a multiple case study. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S15-10.1186/1472-698X-9-S1-S4.PubMed CentralView ArticlePubMed
- Cockcroft A, Andersson N, Omer K, Ansari NM, Khan A, Chaudhry UU, Ansari U: One size does not fit all: local determinants of measles vaccination in four districts of Pakistan. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S4-10.1186/1472-698X-9-S1-S13.PubMed CentralView ArticlePubMed
- Koumaré AK, Traore D, Haidara F, Sissoko F, Traoré I, Dramé S, Sangaré K, Diakité K, Coulibaly B, Togola B, MaÏga A: Evaluation of immunization coverage within the Expanded Program on Immunization in Kita Circle, Mali: a cross-sectional survey. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S13-10.1186/1472-698X-9-S1-S11.PubMed CentralView ArticlePubMed
- Djibuti M, Gotsadze G, Zoidze A, Mataradze G, Esmail LC, Kohler JC: The role of supportive supervision on immunization program outcome - a randomized field trial from Georgia. BMC Int Health Hum Rights. 2009, 9 (Suppl 1): S11-PubMed CentralView ArticlePubMed
- World Health Organization, United Nation's Children Fund: Global Immunization Data. 2009, [http://www.who.int/immunization/newsroom/GID_english.pdf]
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.